Yaarit Ribak

Clinical significance of very high IgE levels (≥1000 IU/mL): Population-based study of 118,211 adults

<scp>IgE</scp> deficiency (&lt;2.5 <scp>IU</scp> / <scp>mL</scp> ) in children: Clinical insights from a population‐based study of 123,393 subjects

Dual biological treatments in immune-mediated disorders: a single center experience

Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events

Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome

Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis

Dupilumab for cancer-associated refractory pruritus

Food‐induced anaphylaxis during infancy is associated with later sleeping and eating disorders

Successful ligelizumab treatment of severe refractory solar urticaria

Food allergy is associated with increased risk of developing psychological disorders: A nationwide study of 603,257 Israelis

B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodies

Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity‐induced rash in patients with multiple myeloma

Severe eosinophilia in hospitalized patients

The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases

Keeping PPE barriers in COVID-19 wards while doing proper auscultation